11-102842734-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002422.5(MMP3):āc.288T>Cā(p.Asp96Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,613,446 control chromosomes in the GnomAD database, including 222,671 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.55 ( 22942 hom., cov: 31)
Exomes š: 0.52 ( 199729 hom. )
Consequence
MMP3
NM_002422.5 synonymous
NM_002422.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.36
Genes affected
MMP3 (HGNC:7173): (matrix metallopeptidase 3) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. This gene encodes an enzyme which degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The enzyme is thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 11-102842734-A-G is Benign according to our data. Variant chr11-102842734-A-G is described in ClinVar as [Benign]. Clinvar id is 403097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMP3 | NM_002422.5 | c.288T>C | p.Asp96Asp | synonymous_variant | 2/10 | ENST00000299855.10 | NP_002413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMP3 | ENST00000299855.10 | c.288T>C | p.Asp96Asp | synonymous_variant | 2/10 | 1 | NM_002422.5 | ENSP00000299855.5 | ||
MMP3 | ENST00000524478.1 | n.*130T>C | non_coding_transcript_exon_variant | 2/4 | 4 | ENSP00000435255.1 | ||||
MMP3 | ENST00000524478.1 | n.*130T>C | 3_prime_UTR_variant | 2/4 | 4 | ENSP00000435255.1 |
Frequencies
GnomAD3 genomes AF: 0.545 AC: 82732AN: 151746Hom.: 22910 Cov.: 31
GnomAD3 genomes
AF:
AC:
82732
AN:
151746
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.573 AC: 143688AN: 250880Hom.: 42158 AF XY: 0.571 AC XY: 77413AN XY: 135570
GnomAD3 exomes
AF:
AC:
143688
AN:
250880
Hom.:
AF XY:
AC XY:
77413
AN XY:
135570
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.518 AC: 757194AN: 1461582Hom.: 199729 Cov.: 64 AF XY: 0.523 AC XY: 380508AN XY: 727052
GnomAD4 exome
AF:
AC:
757194
AN:
1461582
Hom.:
Cov.:
64
AF XY:
AC XY:
380508
AN XY:
727052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.545 AC: 82815AN: 151864Hom.: 22942 Cov.: 31 AF XY: 0.555 AC XY: 41148AN XY: 74194
GnomAD4 genome
AF:
AC:
82815
AN:
151864
Hom.:
Cov.:
31
AF XY:
AC XY:
41148
AN XY:
74194
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2294
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at